Wednesday, November 15, 2006 7:00:00 AM PDT | VentureDeal Staff
SAN FRANCISCO, CA -- Sofinnova Ventures, an early stage venture capital firm, has closed its seventh fund in the amount of $375 million. The firm said their original target was $300 million which was increased due to strong demand by limited partners. Sofinnova invests in early stage life science and IT companies, and intends to allocate two thirds of the fund to life science companies and one third to wireless IT companies. Two thirds of the funds investors are in the US and one third are in Europe, reflecting Sofinnova's ties to France.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
